CN108947909A - A kind of chiral aza ring carbene precursor compound and its synthetic method with imidazolone skeleton - Google Patents

A kind of chiral aza ring carbene precursor compound and its synthetic method with imidazolone skeleton Download PDF

Info

Publication number
CN108947909A
CN108947909A CN201811025530.6A CN201811025530A CN108947909A CN 108947909 A CN108947909 A CN 108947909A CN 201811025530 A CN201811025530 A CN 201811025530A CN 108947909 A CN108947909 A CN 108947909A
Authority
CN
China
Prior art keywords
compound
reaction
chiral
formula
synthetic method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811025530.6A
Other languages
Chinese (zh)
Other versions
CN108947909B (en
Inventor
李�杰
邹东
王佳敏
周碧辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University City College ZUCC
Original Assignee
Zhejiang University City College ZUCC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University City College ZUCC filed Critical Zhejiang University City College ZUCC
Priority to CN201811025530.6A priority Critical patent/CN108947909B/en
Publication of CN108947909A publication Critical patent/CN108947909A/en
Application granted granted Critical
Publication of CN108947909B publication Critical patent/CN108947909B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention discloses a kind of chiral aza ring carbene precursor compound and its synthetic method with imidazolone skeleton, the present invention is using cheap bromoacetyl bromide as raw material, pass through three-step reaction, the novel chiral benzimidazole carbene precursor compound of series structure succinctly can be effectively synthesized, to expand its application category in pharmaceutical intermediate synthetic reaction and organic asymmetric catalysis synthesis.

Description

A kind of chiral aza ring carbene precursor compound and its synthesis with imidazolone skeleton Method
Technical field
The present invention relates to organic synthesis fields, and in particular to a kind of chiral aza ring carbene precursor with imidazolone skeleton Compound and its synthetic method.
Background technique
N-heterocyclic carbine (N-heterocyclic carbenes, NHCs) has become extremely important in current chemical field Ligand be designed to the preparation of metal-organic complex, and then be widely used in homogeneous catalysis, pharmaceutical chemistry, asymmetric close At and Material Field.Although Wanzlick andEarly in the last reagent sixties it has been reported that N-heterocyclic carbine, still Until the isolated free carbenes of the seminars such as Bertrand and Arduengo and until obtain single crystal data, NHCs neck The relevant research in domain just attracts wide public concern.From electrical angle, nitrogen heterocycle carbine ligand belongs to singlet Cabbeen, because with card Guest carbon center sp2The lone pair electrons of hydridization can be stablized by the lone pair electrons of two adjacent nitrogen-atoms, and then be formed in Cabbeen The p track of heart sky.Therefore, NHCs shows the electron-donating and weaker pi-electron acceptance of strong σ, so that they are very suitable into It is applied to homogeneous catalysis for the substitute of Phosphine ligands.In addition, having benefited from excellent efficiency of the NHCs in terms of metal catalytic, accordingly Chiral nitrogen heterocycle carbine ligand has also obtained significant progress.
The current NHC ligand that seminar is developed both at home and abroad, basic structural unit be based primarily upon pentacyclic imidazoles or The structures such as person's glyoxalidine.In recent years, the more special nitrogen heterocycle carbine ligand of some skeleton structures is reported successively.Include Not in the big ring azo-cycle carbenes of traditional penta azacyclo carbenes (including hexa-atomic NHCs ligand and seven yuan of NHCs ligands) There is the nitrogen heterocycle carbine ligand of carbonyl functional group with skeleton.The latter one skeleton is due to special Electrical distribution by this The concern of area research person.
2008, Lavigne et al. reported skeleton with the hexa-atomic of carbonyl functional group in American Chemical Society's meeting will for the first time The synthesis of the rhodium complex of azepine carbenes, and its electrical property and structure feature are inquired into, structure is as follows.
Then (2009), the Research team report five yuan of similar Cabbeen rhodium complexes with imidazolone skeleton again Synthesis, and it is prepared for its enol form isomer, specific structure is as follows.
The same year, Bielawski seminar are prepared for hexa-atomic Cabbeen free ligand and itself and iridium of the skeleton with carbonyl Complex compound, and careful parsing is carried out to structure by single crystal diffraction, specific structure is as follows, and related research result is published in beauty In state's Society will.
Then, which is prepared for the complex compound that same carbenes and metal rhodium are formed and the network formed with copper again Object is closed, and is well used in olefin interconversion decomposition reaction.
And it is visited by comparing the structure and distribution of charges of hexa-atomic carbenes and the hexa-atomic carbenes with carbonyl Begging for introduce in Cabbeen skeleton electrically influences brought by carbonyl.
Recently, the design of this seminar has synthesized the serial new chiral carbene precursor salt with dihydropyrimidinonesand skeleton, and Medium enantioselectivity on the upper side, the chirality that building series plays a significant role are obtained in the not addition reaction of catalysis aromatic aldehyde Diaryl secondary alcohols.
The development course of chiral carbenes of the skeleton with carbonyl is made a general survey of, which is still in the starting stage.Although such as This, the unique electrical property that the carbenes of such skeleton are embodied novel framework characteristic makes it have very big attraction Power and researching value.Therefore, the synthetic method tool of ligand and its metal complex of the new parent nucleus with carbonyl functional group is developed It is significant, the connotation of carbene chemistry taxology itself can be not only enriched, and can apply to asymmetric reaction and reduction portion The production cost of broad range drug synthesis intermediate.
Summary of the invention
The purpose of the present invention is designing a succinct organic synthesis route, a kind of chirality with imidazolone skeleton is proposed Aza ring carbene precursor compound and its synthetic method, to expand it in pharmaceutical intermediate synthetic reaction and organic asymmetric conjunction At the application category in reaction.Specific technical solution is as follows:
A kind of chiral aza ring carbene precursor compound with imidazolone skeleton, which is characterized in that the chirality azacyclo- Carbene precursor compound are as follows:
Or its enantiomter:
Wherein, R1Selected from phenyl, benzyl, tert-butyl, isopropyl, methyl and isobutyl group;
R2 is selected from phenyl, 1- naphthalene, 2- naphthalene, benzyl, isopropyl, tert-butyl and cyclohexyl;
R3Selected from chloride ion, bromide ion, tetrafluoroborate ion and hexafluorophosphoricacid acid ions.
Further, the structure of the chirality aza ring carbene precursor compound is selected from:
A kind of synthetic method of chiral aza ring carbene precursor compound as described in claim 1, which is characterized in that should Method includes the following steps:
(I) will carry out instead under triethylamine effect in aprotic solvent such as logical formula (I) compound represented and aromatic amine It answers, then collection type (II) compound, reaction formula are as follows from reaction product:
(II) in aprotic solvent, will the amides compound as shown in general formula (II) and chiral primary amine alkali effect Under reacted, then collection type (III) compound, reaction formula are as follows from reaction product:
(III), will the chiral diamine as shown in general formula (III), trimethyl orthoformate or orthoformic acid three in aprotic solvent Ethyl ester is reacted under lewis acid effect, and then collection type (IV) compound, reaction formula are as follows from reaction product:
Further, in the step (I), the molar ratio of formula (I) compound and arylamine is 1.1:1, reaction temperature It is 20~30 DEG C, the reaction time is 1~3 hour.
Further, in the step (II), reaction temperature is 20~30 DEG C, and the reaction time is 10~16 hours, formula (II) compound, chiral primary amine, alkali molar ratio be 1:1.2:2.
Further, in the step (III), reaction temperature is 100~120 DEG C, and the reaction time is 8~12 hours, formula (III) compound, orthoformate, lewis acidic molar ratio are 1:1:1~2.
Beneficial effects of the present invention are as follows:
Chiral nitrogen heterocycle carbine ligand with imidazolone skeleton is the research frontier of Organometallic Chemistry, due to Imidazoles ring skeleton introduces carbonyl functional group, will significantly change distribution and the catalytic performance of the cloud density of such carbenes Deng so that it has more unique property in catalysis reaction.The synthetic method of such ligand is rare, and the present invention is with cheap bromine Acetyl bromide is raw material, by three-step reaction, succinctly can effectively synthesize the novel chiral aza ring carbene precursor salt of series structure, And chiral centre can be introduced in N atom side chain.Such ligand can be used as ligand and metal center forms complex compound, urge in metal Change in reaction system and show superior reactivity, and the catalysis for being expected to obtain high enantiomter in asymmetric reaction produces Object.
Specific embodiment
Below according to preferred embodiment the present invention is described in detail, the objects and effects of the present invention be will become more apparent, with Under in conjunction with the embodiments, the present invention will be described in further detail.It should be appreciated that specific embodiment described herein is only used To explain the present invention, it is not intended to limit the present invention.
The synthetic route of chiral aza ring carbene precursor compound of the invention is as follows:
Wherein, (I) is aromatic amine, triethylamine, methylene chloride;(II) chiral primary amine, alkali, tetrahydrofuran;(III) orthoformic acid Triethyl or trimethyl orthoformate, ammonium salt (such as ammonium tetrafluoroborate, ammonium chloride).
The representative synthetic method (logical method 1) of compound ii:
Under nitrogen protection, 4mmol aromatic amine (1 equivalent), 8mmol triethylamine (2 equivalent) are dissolved in dry methylene chloride It in (40mL), under condition of ice bath (0 DEG C), is added 4.4mmol compound (I) (1.1 equivalent), after being stirred at room temperature 3 hours, is added Then the dilution of 20mL methylene chloride is added the washing of 30mL saturated ammonium chloride solution, separates organic layer, through saturated common salt water washing, Organic layer is separated, filters evaporated under reduced pressure after anhydrous sodium sulfate is dry, mixture column chromatography for separation (PE:EA=10:1) obtains product Ⅱ。
The representative synthetic method (logical method 2) of compound III:
Under nitrogen protection, 4.0mmol sodium hydride (2 equivalent) and 2.4mmol chiral primary amine (1.2 equivalent) are dissolved in 10mL's THF solution is added dropwise to the THF solution (10mL) of 2.0mmol compound (II) (1 equivalent), stirs 14 hours at room temperature, reaction knot Shu Hou is added the washing of 15mL saturated ammonium chloride solution, separates organic layer, through saturated common salt water washing, separates organic layer, anhydrous sulphur Evaporated under reduced pressure is filtered after sour sodium is dry, mixture column chromatography for separation (PE:EA=8:1) obtains product III.
The representative synthetic method (logical method 3) of compounds Ⅳ:
1mmol compound III (1 equivalent), 1mmol triethyl orthoformate (1 equivalent) and 1mmol ammonium tetrafluoroborate are mixed, It is reacted under 120 DEG C of heating conditions 12 hours, after reaction, by mixture column chromatography for separation (CH2Cl2:CH3OH=50:1~ 20:1) obtain product IV.
Embodiment 1
The preparation and representation of compound ii -1:
Under nitrogen protection, by 4mmol trimethyl aniline (562 μ L, 4mmol) and 8mmol triethylamine (1112 μ L, It 8mmol) is dissolved in dry methylene chloride (40mL), under condition of ice bath (0 DEG C), 1.07g compound (I) (4.4mmol) is added and exists After being stirred at room temperature 3 hours, the dilution of 20mL methylene chloride is added, the washing of 30mL saturated ammonium chloride solution is then added, separates organic Layer separates organic layer, filters evaporated under reduced pressure, mixture column chromatography for separation after anhydrous sodium sulfate is dry through saturated common salt water washing (PE:EA=10:1) product II -1, yield 94% are obtained.
Embodiment 2
The preparation and representation of compound ii -2:
Preparation condition is the same as embodiment 1, yellow oil, yield 90%.
Embodiment 3
The preparation and representation of compound III -1:
Under nitrogen protection, sodium hydride (96mg, 4mmol) and chiral primary amine (309 μ L, 2.4mmol) are dissolved in the THF of 10mL Solution is added dropwise to the THF solution (10mL) of compound (II -1) (596mg, 2.0mmol), stirs 14 hours at room temperature, reaction knot Shu Hou is added the washing of 15mL saturated ammonium chloride solution, separates organic layer, through saturated common salt water washing, separates organic layer, anhydrous sulphur Evaporated under reduced pressure is filtered after sour sodium is dry, mixture column chromatography for separation (PE:EA=8:1) obtains product III -1;Yield is 81%;1H NMR(500MHz,CDCl3)δ:8.80(s,1H),7.37–7.30(m,4H),7.24–7.20(m,1H),6.87(s,2H),4.02 (q, J=6.7Hz, 1H), 2.25 (s, 3H), 2.13 (s, 6H), 1.41 (d, J=6.7Hz, 3H), 1.39 (s, 3H), 1.38 (s, 3H).
Embodiment 4
The preparation and representation of compound III -2:
Preparation condition is the same as embodiment 3, white solid, yield 79%;1H NMR(500MHz,CDCl3)δ:8.87(s, 1H), 7.33-7.27 (m, 4H), 7.24-7.20 (m, 1H), 6.88 (s, 2H), 3.72 (dd, J=8.1,5.7Hz, 1H), 2.26 (s, 3H), 2.14 (s, 6H), 1.82-1.63 (m, 2H), 1.35 (s, 3H), 1.30 (s, 3H), 0.79 (t, J=7.4Hz, 3H)
Embodiment 5
The preparation and representation of compound III -3:
Preparation condition is the same as embodiment 3, white solid, yield 72%;1H NMR(500MHz,CDCl3)δ:9.02(s, 1H),6.88(s,2H),2.79–2.72(m,1H),2.26(s,3H),2.18(s,6H),1.79–1.65(m,6H),1.54– 1.37 (m, 11H), 1.06 (d, J=6.5Hz, 3H)
Embodiment 6
The preparation and representation of compound III -4:
Preparation condition is the same as embodiment 3, white solid, yield 73%;1H NMR(500MHz,CDCl3)δ:9.09(s, 1H), 6.88 (s, 2H), 2.66 (q, J=6.4Hz, 1H), 2.26 (s, 3H), 2.18 (s, 6H), 1.47 (s, 3H), 1.43 (s, 3H), 1.08 (d, J=6.4Hz, 3H), 0.94 (s, 9H)
Embodiment 7
The preparation and representation of compound III -5:
Preparation condition is the same as embodiment 3, white solid, yield 75%;1H NMR(500MHz,CDCl3)δ:9.10(s, 1H),7.28–7.25(m,1H),7.18–7.16(m,2H),3.06–3.01(m,2H),2.78–2.73(m,1H),1.79–1.66 (m, 5H), 1.46 (s, 3H), 1.45 (s, 3H), 1.39-1.11 (m, 18H), 1.08 (d, J=6.5Hz, 3H)
Embodiment 8
The preparation and representation of compound III -6:
Preparation condition is the same as embodiment 3, white solid, yield 79%;1H NMR(500MHz,CDCl3)δ:9.17(s, 1H), 7.27-7.24 (m, 1H), 7.17 (d, J=7.7Hz, 2H), 3.03 (m, 2H), 2.67 (q, J=6.4Hz, 1H), 1.49 (s, 3H), 1.44 (s, 3H), 1.22 (d, J=6.9Hz, 6H), 1.19 (d, J=6.9Hz, 6H), 1.10 (d, J=6.4Hz, 3H),0.94(s,9H).
Embodiment 9
The preparation and representation of compound III -7:
Preparation condition is the same as embodiment 3, white solid, yield 81%;1H NMR(500MHz,CDCl3)δ:9.09(s, 1H),7.40–7.38(m,1H),7.25–7.24(m,1H),7.19–7.10(m,5H),4.12(m,1H),3.03–2.98(m, 2H),2.86–2.80(m,1H),2.75–2.69(m,1H),2.00–1.79(m,4H),1.61(s,3H),1.60(s,3H), 1.48–1.33(m,1H),1.19–1.16(m,6H).
Embodiment 10
The preparation and representation of compounds Ⅳ -1:
By compound III -1 (338mg, 1mmol), triethyl orthoformate (148mg, 1mmol) and ammonium tetrafluoroborate (126mg, 1.2mmol) mixing, reacts 12 hours under 120 DEG C of heating conditions, after reaction, by mixture column chromatography for separation (CH2Cl2:CH3OH=50:1~20:1) obtain product IV -1, yield 70%.
Embodiment 11
The preparation and representation of compounds Ⅳ -2:
Preparation condition is the same as embodiment 10, white solid, yield 69%;1H NMR(500MHz,CDCl3)δ:8.59(s, 1H), 7.38 (t, J=5.8Hz, 2H), 7.35-7.31 (m, 3H), 6.82 (s, 2H), 4.57 (t, J=7.9Hz, 1H), 2.23 (s, 3H), 2.10 (s, 6H), 1.67 (s, 3H), 1.54 (s, 3H), 1.26 (s, 2H), 1.06 (t, J=7.3Hz, 3H)
Embodiment 12
The preparation and representation of compounds Ⅳ -3:
Preparation condition is the same as embodiment 10, white solid, yield 73%;1H NMR(500MHz,CDCl3)δ:。1H NMR (500MHz,CDCl3)δ:9.08(s,1H),7.02(s,1H),7.00(s,1H),3.68(m,1H),2.32(s,3H),2.17 (s,3H),2.12(s,3H),2.09–1.60(m,20H).
Embodiment 13
The preparation and representation of compounds Ⅳ -4:
Preparation condition is the same as embodiment 10, white solid, yield 68%;1H NMR(500MHz,CDCl3)δ:9.57(s, 1H), 7.05 (s, 1H), 6.98 (s, 1H), 3.79 (q, J=7.1Hz, 1H), 2.32 (s, 3H), 2.20 (s, 3H), 2.12 (s, 3H), 1.81 (s, 3H), 1.73 (s, 3H), 1.69 (d, J=7.1Hz, 3H), 1.13 (s, 9H)
Embodiment 14
The preparation and representation of compounds Ⅳ -5:
Preparation condition is the same as embodiment 10, white solid, yield 72%;1H NMR(500MHz,CDCl3)δ:9.76(s, 1H), 7.52 (t, J=7.8Hz, 1H), 7.30 (d, J=3.5Hz, 1H), 7.15 (d, J=7.7Hz, 1H), 3.78 (m, 1H), 2.54 (m, 1H), 2.45 (m, 1H), 2.09-1.91 (m, 4H) 1.80-1.73 (m, 7H), 1.64 (d, J=2.5Hz, 3H), 1.60–1.16(m,18H).
Embodiment 15
The preparation and representation of compounds Ⅳ -6:
Preparation condition is the same as embodiment 10, white solid, yield 65%;1H NMR(500MHz,CDCl3)δ:9.70(s, 1H), 7.53 (t, J=7.8Hz, 1H), 7.34 (d, J=7.9Hz, 1H), 7.28 (d, J=7.9Hz, 1H), 3.87 (q, J= 7.1Hz, 1H), 2.60 (m, 1H), 2.44 (m, 1H), 1.84 (s, 3H), 1.76 (s, 3H), 1.71 (d, J=7.1Hz, 3H), 1.35–1.12(m,21H)。
Embodiment 16
The preparation and representation of compounds Ⅳ -7:
Preparation condition is the same as embodiment 10, white solid, yield 78%;1H NMR(500MHz,CDCl3)δ:8.57(s, 1H),7.38–7.14(m,7H),3.55–3.50(m,2H),3.15–2.82(m,5H),1.75(s,6H),1.46–1.12(m, 16H).
It will appreciated by the skilled person that being not used to limit the foregoing is merely the preferred embodiment of invention System invention, although invention is described in detail referring to previous examples, for those skilled in the art, still It can modify to the technical solution of aforementioned each case history or equivalent replacement of some of the technical features.It is all Within the spirit and principle of invention, modification, equivalent replacement for being made etc. be should be included within the protection scope of invention.

Claims (6)

1. a kind of chiral aza ring carbene precursor compound with imidazolone skeleton, which is characterized in that the chirality azacyclo- card Guest's precursor compound are as follows:
Or its enantiomter:
Wherein, R1Selected from phenyl, benzyl, tert-butyl, isopropyl, methyl and isobutyl group.
R2 is selected from phenyl, 1- naphthalene, 2- naphthalene, benzyl, isopropyl, tert-butyl and cyclohexyl.
R3Selected from chloride ion, bromide ion, tetrafluoroborate ion and hexafluorophosphoricacid acid ions.
2. the chiral aza ring carbene precursor compound according to claim 1 with imidazolone skeleton, which is characterized in that The structure of the chirality aza ring carbene precursor compound is selected from:
3. a kind of synthetic method of chiral aza ring carbene precursor compound as described in claim 1, which is characterized in that the party Method includes the following steps:
(I) will react under triethylamine effect in aprotic solvent such as logical formula (I) compound represented and aromatic amine, Then collection type (II) compound, reaction formula are as follows from reaction product:
(II) in aprotic solvent, will the amides compound as shown in general formula (II) and chiral primary amine in the presence of alkali into Row reaction, then collection type (III) compound, reaction formula are as follows from reaction product:
(III) in aprotic solvent, will chiral diamine, trimethyl orthoformate or triethyl orthoformate as shown in general formula (III), It is reacted under lewis acid effect, then collection type (IV) compound, reaction formula are as follows from reaction product:
4. synthetic method according to claim 3, which is characterized in that in the step (I), formula (I) compound and virtue The molar ratio of base amine is 1.1:1, and reaction temperature is 20~30 DEG C, and the reaction time is 1~3 hour.
5. synthetic method according to claim 3 or 4, which is characterized in that in the step (II), reaction temperature 20 ~30 DEG C, the reaction time be 10~16 hours, formula (II) compound, chiral primary amine, alkali molar ratio be 1:1.2:2.
6. synthetic method according to claim 5, which is characterized in that in the step (III), reaction temperature be 100~ 120 DEG C, the reaction time is 8~12 hours, and formula (III) compound, orthoformate, lewis acidic molar ratio are 1:1:1~2.
CN201811025530.6A 2018-09-04 2018-09-04 Chiral N-heterocyclic carbene precursor compound with imidazolone framework and synthesis method thereof Active CN108947909B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811025530.6A CN108947909B (en) 2018-09-04 2018-09-04 Chiral N-heterocyclic carbene precursor compound with imidazolone framework and synthesis method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811025530.6A CN108947909B (en) 2018-09-04 2018-09-04 Chiral N-heterocyclic carbene precursor compound with imidazolone framework and synthesis method thereof

Publications (2)

Publication Number Publication Date
CN108947909A true CN108947909A (en) 2018-12-07
CN108947909B CN108947909B (en) 2020-09-11

Family

ID=64475704

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811025530.6A Active CN108947909B (en) 2018-09-04 2018-09-04 Chiral N-heterocyclic carbene precursor compound with imidazolone framework and synthesis method thereof

Country Status (1)

Country Link
CN (1) CN108947909B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102083798A (en) * 2008-04-09 2011-06-01 马特里亚公司 Ruthenium olefin metathesis catalysts bearing N-heterocyclic carbene ligands with substituted backbone
CN105772094A (en) * 2016-04-21 2016-07-20 上海化工研究院 Chiral nitrogen heterocycle carbene type catalyst and application thereof
CN108456172A (en) * 2018-04-20 2018-08-28 浙江大学城市学院 A kind of chiral aza ring carbene precursor compound and its preparation method and application with benzimidazole skeleton

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102083798A (en) * 2008-04-09 2011-06-01 马特里亚公司 Ruthenium olefin metathesis catalysts bearing N-heterocyclic carbene ligands with substituted backbone
CN105772094A (en) * 2016-04-21 2016-07-20 上海化工研究院 Chiral nitrogen heterocycle carbene type catalyst and application thereof
CN108456172A (en) * 2018-04-20 2018-08-28 浙江大学城市学院 A kind of chiral aza ring carbene precursor compound and its preparation method and application with benzimidazole skeleton

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SARAH M. BRONNER,ET AL.: "Ru-based Z-selective metathesis catalysts with modified cyclometalated carbene ligands", 《CHEM. SCI.》 *
周碧辉: "新型手性大环卡宾配体的设计合成及其在催化反应中的应用", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 *

Also Published As

Publication number Publication date
CN108947909B (en) 2020-09-11

Similar Documents

Publication Publication Date Title
EP1993728B1 (en) Process for preparing transition metal-carbene complexes
EP2275429A2 (en) Method for producing a ruthenium complex
ES2279952T3 (en) HYDROXIDIFOSFINAS AND ITS USE IN CATALYSIS.
ITPD20070237A1 (en) NEW BINDERS OF THE BENZO CLASS [CH]
CN106928128B (en) A kind of alkyl diradical and preparation method thereof
EP2695887A1 (en) Novel ruthenium complex and process for producing optically active alcohol compound using same as catalyst
CN109180682A (en) A kind of chiral aza ring carbene precursor compound and preparation method thereof with bicyclic skeleton
EP2128167A1 (en) Phosphoroamide compound, method for producing the same, ligand, complex, catalyst, and method for producing optically active alcohol
CN108947909A (en) A kind of chiral aza ring carbene precursor compound and its synthetic method with imidazolone skeleton
CN111229312B (en) Solvent-free catalyst and preparation method and application thereof
CN109734667B (en) Polysubstituted imidazole compound and synthesis method and application thereof
CN114478245A (en) Asymmetric synthesis method of chiral gamma-alkynyl-alpha-keto acid ester compound
CN110143962B (en) Novel method for synthesizing benzimidazole [1,2-a ] quinoline derivative
KR101614887B1 (en) Method for preparation of amide and imide from alcohol and nitrogen Containing Compound
CN112778191A (en) Visible light mediated method for synthesizing allyl alcohol compound containing indole skeleton
CN102304007A (en) Asymmetric catalytic hydrogenation reaction method of intra-annular N-alkylimine
CN107382874B (en) The preparation method and applications of a kind of chirality six-membered heterocycle carbene precursor salt
DE10155064A1 (en) Rhodium and iridium complexes
Geldbach et al. Protonation and NMR studies on 13C-acetate enriched Ru (OAc) 2 (Binap). Acetate as a source of water in P C bond splitting
CN102731484B (en) Preparation method for prodigiosins analogue
CN115215783B (en) Propargyl substituted chiral 3-amino-3, 3-disubstituted oxindole compound, and synthetic method and application thereof
CN109575073B (en) 4-phosphonyl 1-naphthylamine compound and preparation method thereof
Dalai et al. Diastereoselective reductive N-alkylation of (R, R)-trans-1, 2-diaminocyclohexane with prochiral ketones using the Ti (OiPr) 4/NaBH4 system
Wu et al. Synthesis, structure, and chirality of hydroxyl-and carboxyl-functionalized cubane-like photodimers of 2-naphthalene
KR100640719B1 (en) Gadolinium complex comprising chiral [iminophosphoranyl]ferrocene ligands and method for the preparation thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant